Immuron Ltd is a biotechnology company focused on developing and commercializing innovative immunotherapeutic products aimed at treating various diseases, primarily those associated with the immune system and gastrointestinal health

The company uses its proprietary technology to create therapeutic agents that target specific pathways related to immune response, with applications in conditions such as traveler's diarrhea, inflammatory bowel disease, and other inflammatory disorders. Immuron is dedicated to advancing its research and development efforts to improve patient outcomes through targeted therapies that leverage the body's immune mechanisms.